Genetic transfer of PNAS-4 induces apoptosis and enhances sensitivity to gemcitabine in lung cancer

Cell Biology International

Volumn 33, Issue 3, 2009, Pages 276-282

  Hou, Shengyan ^a   Zhao, Zhiwei ^a   Yan, Fei ^a   Chen, Xiancheng ^a   Deng, Hongxin ^a   Chen, Xiang ^a   Wang, Yongsheng ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Gemcitabine; Gene therapy; Lung cancer; PNAS 4

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; ANTINEOPLASTIC AGENT; GEMCITABINE; LIPOSOME; PROTEIN PNAS 4; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; DRUG POTENTIATION; FEMALE; GENE; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; NUDE MOUSE; PLASMID; PNAS 4 GENE; TREATMENT DURATION;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; GENE TRANSFER TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; TRANSPLANTATION, HETEROLOGOUS;

MUS MUSCULUS;

EID: 61449103474     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.11.014     Document Type: Article

References (29)

1. Braakhuis B.J.M., Van Dongen G.A.M.S., Vermorken J.B., and Snow G.B. Preclinical in vivo activity of 2'-2'-difluorodeoxycytidine (gemcitabine) against human head and neck cancer. Cancer Res 51 (1991) 211-214
2. Cascalló M., Calbó J., Capellà G., Fillat C., Pastor-Anglada M., and Mazo A. Enhancement of gemcitabine-induced apoptosis by restoration of p53 function in human pancreatic tumors. Oncology 68 (2005) 179-189
3. Chen M., Hough A.M., and Lawrence T.S. The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization. Cancer Chemother Pharmacol 45 (2000) 369-374
4. Comella P., and Southern Italy Cooperative Oncology Group. Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer. Semin Oncol 28 (2001) 7-10
5. Crino L., Scagliotti G., Marangolo M., Figoli F., Clerici M., De Marinis F., et al. Cisplatin-gemcitabine combination in advanced non-small cell lung cancer: a phase II study. J Clin Oncol 15 (1997) 297-303
6. Daniel S.B., 2006. Modeling the p53 gene regulatory network: author's (doctoral) dissertation, London University, London.
7. Day C.P., Rau K.M., Qiu L., Liu C.W., Kuo H.P., Xie X., et al. Mutant Bik expression mediated by the enhanced minimal topoisomerase IIalpha promoter selectively suppressed breast tumors in an animal model. Cancer Gene Ther 13 (2006) 706-719
8. Dolnikov A., Millington M., Sun L.Q., and Symonds G. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation. Cancer Gene Ther 7 (2000) 1491-1503
9. Dubrez L., Coll J.L., Hurbin A., de Fraipont F., Lantejoul S., and Favrot M.C. Cell cycle arrest is sufficient for p53-mediated tumor regression. Gene Ther 8 (2001) 1705-1712
10. Eastham J.A., Hall S.J., Sehgal I., Wang J., Timme T.L., Yang G., et al. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. Cancer Res 55 (1995) 5151-5155
11. Elliott M.J., Stilwell A., Dong Y.B., Yang H.L., Wong S.L., Wrightson W.R., et al. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Cancer Gene Ther 9 (2002) 453-463
12. Favrot M., Coll J.L., Louis N., and Negoescu A. Cell death and cancer: replacement of apoptotic genes and inactivation of death suppressor genes in therapy. Gene Ther 5 (1998) 728-739
13. Filippov V., Filippova M., Sinha D., and Duerksen-Hughes P.J. Proc Am Assoc Cancer Res 46 (2005) (Abstract 3050)
14. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82 (1990) 4-6
15. Fulda S., and Debatin K.M. Targeting apoptosis pathways in cancer therapy. Curr Cancer Drug Targets 4 (2004) 569-576
16. Hertel L.W., Boder G.B., Kroin J.S., Rinzel S.M., Poore G.A., Todd G.C., et al. Evaluation of the anti-tumor activity of gemcitabine (2'-2'-difluoro-2'-deoxycytidine). Cancer Res 50 (1990) 4417-4422
17. Hirko A., Tang F., and Hughes J.A. Cationic lipid vectors for plasmid DNA delivery. Curr Med Chem 10 (2003) 1185-1193
18. Hollstein M., Sidransky D., and Vogelstemn B. and Harris CC. p53 mutations in human cancers. Science 253 (1991) 49-53
19. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics. CA Cancer J Clin 2006 56 (2006) 106-130
20. Kurdow R., Schniewind B., Zoefelt S., Boenicke L., Boehle A.S., Dohrmann P., et al. Apoptosis by gemcitabine in non-small cell lung cancer cell line KNS62 is induced downstream of caspase 8 and is profoundly blocked by Bcl-xL over-expression. Langenbecks Arch Surg 390 (2005) 243-248
21. Leon L., Cueva-Banuelos J.F., Huidobro G., Firvida J.L., Amenedo M., Lazaro M., et al. Gemcitabine, cisplatin and vinorelbine as induction chemotherapy followed by radical therapy in stage III non-small-cell lung cancer: a multicentre study of galician-lung-cancer-group. Lung Cancer 40 (2003) 215-220
22. Lin X., Chen X., Wei Y., Zhao J., Fan L., Wen Y., et al. Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice. Gynecol Oncol 104 (2007) 540-546
23. Noda I., Fujieda S., Seki M., Tanaka N., Sunaga H., Ohtsubo T., et al. Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells. Int J Cancer 80 (1999) 279-284
24. Oltersdorf T., Elmore S.W., Shoemaker A.R., Armstrong R.C., Augeri D.J., Belli B.A., et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 435 (2005) 677-681
25. Opalka B., Dickopp A., and Kirch H.C. Apoptotic genes in cancer therapy. Cells, Tissues, Organs 172 (2002) 126-132
26. Ueno N.T., Bartholomeusz C., Xia W., Anklesaria P., Bruckheimer E.M., Mebel E., et al. Systemic gene therapy in human xenograft tumor models by liposomal delivery of the E1A gene. Cancer Res 62 (2002) 6712-6716
27. Wei Y.Q., Zhao X., Kariya Y., Fukata H., Teshigawara K., and Uchida A. Induction of apoptosis by quercetin: involvement of heat shock protein. Cancer Res 54 (1994) 4952-4957
28. Yan F., Qian M., Yang F., Cai F., Yuan Z., Lai S., et al. A novel pro-apoptosis protein PNAS-4 from Xenopus laevis: cloning, expression, purification, and polyclonal antibody production. Biochemistry (Mosc) 72 (2007) 664-671
29. Zhao Y., Lu S., Wu L., Chai G., Wang H., Chen Y., et al. Acetylation of p53 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21(Waf1/Cip1). Mol Cell Biol 26 (2006) 2782-2790